News release
From:
JAMA
About The Study: This study found that vaccination against SARS-CoV-2 prior to and during pregnancy, before COVID-19 diagnosis, was associated with a lower risk of severe maternal disease and preterm birth regardless of variant time period.
Organisation/s:
University of British Columbia, Canada
Funder:
This project was supported by
funding from the Public Health Agency of Canada
through the COVID-19 Immunity Task Force
(2021-HQ-000100 and 2122-HQ-000436), the
Canadian Institutes of Health Research (447634),
and the BCWomen’s Health Foundation
(89026 7537 RR0001).